Original Research
Accepted on 13 May 2024
Adverse events in different administration routes of Semaglutide: a pharmacovigilance study based on the FDA Adverse Event Reporting System
in Drugs Outcomes Research and Policies
Original Research
Accepted on 13 May 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 13 May 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 13 May 2024
in Drugs Outcomes Research and Policies
Correction
Accepted on 13 May 2024
in Drugs Outcomes Research and Policies
Systematic Review
Published on 13 May 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 10 May 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 10 May 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 09 May 2024
in Drugs Outcomes Research and Policies
Review
Accepted on 06 May 2024
in Drugs Outcomes Research and Policies
Review
Published on 06 May 2024
in Drugs Outcomes Research and Policies
Brief Research Report
Published on 02 May 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 01 May 2024
in Drugs Outcomes Research and Policies
Systematic Review
Published on 01 May 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 30 Apr 2024
in Drugs Outcomes Research and Policies
Review
Accepted on 30 Apr 2024
in Drugs Outcomes Research and Policies
Opinion
Accepted on 29 Apr 2024
in Drugs Outcomes Research and Policies